Difficulty: Medium
Average Score: 74%
Practice
The fetal/neonatal lung substance that improves pulmonary compliance by decreasing alveolar surface tension is
Correct answer
C
Rationale
The correct answer to the question is C) surfactant. Surfactant is a substance produced by type II alveolar cells in the lungs, especially in the late stages of fetal development and after birth. It plays a crucial role in reducing surface tension within the alveoli, preventing their collapse during exhalation and maintaining pulmonary compliance. This process is essential for efficient gas exchange and proper lung function.
Option A) meconium is the first stool of a newborn and is not related to improving pulmonary compliance. Option B) prostaglandin is a lipid compound that has various physiological effects but is not directly involved in reducing alveolar surface tension.
Educationally, understanding the role of surfactant in the lungs is vital for students studying anatomy and physiology, particularly in comprehending respiratory function and the adaptations required for the transition from fetal to neonatal life. This knowledge also has clinical relevance in neonatal medicine, where surfactant deficiency can lead to respiratory distress syndrome in premature infants.
Option A) meconium is the first stool of a newborn and is not related to improving pulmonary compliance. Option B) prostaglandin is a lipid compound that has various physiological effects but is not directly involved in reducing alveolar surface tension.
Educationally, understanding the role of surfactant in the lungs is vital for students studying anatomy and physiology, particularly in comprehending respiratory function and the adaptations required for the transition from fetal to neonatal life. This knowledge also has clinical relevance in neonatal medicine, where surfactant deficiency can lead to respiratory distress syndrome in premature infants.